Orbital corticosteroid injections for the treatment of active thyroid eye disease

Orbital corticosteroid injections for the treatment of active thyroid eye disease

PurposeTo study the efficacy of orbital injections of triamcinolone acetonide mixed 1:1 with dexamethasone in the treatment of active thyroid eye disease.MethodsPatients that received orbital injection(s) of triamcinolone acetonide mixed 1:1 with dexamethasone for thyroid eye disease were included i...

Full description

Bibliographic Details
Main Authors:	Kevin T. Eid, Peter M. Kally, Alon Kahana
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Ophthalmology
Subjects:	graves orbitopathy corticosteroid orbital thyroid Kenalog clinical activity
Online Access:	https://www.frontiersin.org/articles/10.3389/fopht.2023.1296092/full

Similar Items

Iodine contrast should be avoided in patients with thyroid eye disease
by: Jane Z. Spadaro, et al.
Published: (2024-09-01)

Traumatic Orbital Floor Fracture Causing Therapeutic Orbital Decompression in Thyroid Eye Disease
by: Patrick Buoniconti, et al.
Published: (2022-12-01)

Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review
by: Nickisa M. Hodgson, et al.
Published: (2019-12-01)

Orbital Inflammation in Thyroid Eye Disease: Stress Responses and Their Implications
by: Tracy Aoun, et al.
Published: (2024-01-01)

Graves’ ophthalmopathy – thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019-08-01)

Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
by: Neeraja Boddu, et al.
Published: (2017-07-01)

Minimally invasive surgery for thyroid eye disease
by: Milind Neilkant Naik, et al.
Published: (2015-01-01)

Targeted immunotherapies for Graves’ thyroidal & orbital diseases
by: Alan Chun Hong Lee, et al.
Published: (2025-03-01)

Orbital Radiotherapy for Graves’ Ophthalmopathy: Single Institutional Experience of Efficacy and Safety
by: Madalina La Rocca, et al.
Published: (2025-02-01)

Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves’ disease
by: Nami Suzuki, et al.
Published: (2025-01-01)

Steroid-resistant Graves' orbitopathy: Therapeutic options
by: Klet Sanja, et al.
Published: (2023-01-01)

Practice Patterns in Orbital Decompression Surgery Among American Society of Ophthalmic Plastic and Reconstructive Surgery Members
by: Sarah W. DeParis, et al.
Published: (2019-08-01)

Effectiveness of educational materials on levels of knowledge of thyroid associated orbitopathy in an endocrinology clinic
by: Wajiha J. Kheir, et al.
Published: (2023-12-01)

Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters
by: Lilly H. Wagner, et al.
Published: (2022-11-01)

Clinical, Hormonal, and Ultrasound Characteristics of Patients with Newly Diagnosed Graves’ Disease And Different Thyroid Antibody Profiles
by: Mekova R., et al.
Published: (2019-05-01)

Risk factors for thyroid-associated orbitopathy due to Graves' disease
by: Tauseef Nabi, et al.
Published: (2021-01-01)

Thyroid disease and associated ophthalmopathy
by: Ricardo Concepción, et al.
Published: (2022-04-01)

Preliminary evidence of the association between DNAm and orbital volumetry in GO
by: Ya-Fen Hu, et al.
Published: (2020-07-01)

Graves' orbitopathy treated with immunosuppressive therapy and orbital radiotherapy in a tertiary care endocrine centre: case series
by: D. C. Kottahachchi, et al.
Published: (2016-08-01)

Case report: Periorbital pilomatricoma: a rare benign skin tumor misdiagnosed as cellulitis
by: Rahul Kumar, et al.
Published: (2025-01-01)

Lacrimal gland enlargement as an early clinical or radiological sign in thyroid orbitopathy
by: James Khu, et al.
Published: (2017-04-01)

Concurrent occurrence of thyroid-associated orbitopathy and idiopathic orbital inflammatory diseases
by: Sarala Sankar, et al.
Published: (2022-01-01)

Subconjunctival orbital fat prolapse and thyroid associated orbitopathy: a clinical association
by: Chatzistefanou KI, et al.
Published: (2017-02-01)

Are severe forms of thyroid eye disease common in the indian population? Clinical characteristics of 136 patients from a tertiary eye care centre
by: Dhakshini L Subramaniam, et al.
Published: (2023-01-01)

Adipocytokines in Graves’ orbitopathy and the effect of high-dose corticosteroids
by: Jan Schovanek, et al.
Published: (2021-01-01)

Selenium supplements: is it advisable to use them in treatment of pathology of the thyroid gland?
by: V. Katerenchuk, et al.
Published: (2022-04-01)

Hypo vs. hyperthyroid eye disease: is there any difference?
by: Bahram Eshraghi, et al.
Published: (2023-02-01)

Thyroid Eye Disease
by: Ramy Rashad, et al.
Published: (2022-12-01)

Application of artificial intelligence in the assessment of thyroid eye disease (TED) - a scoping review
by: Chiaw-Ling Chng, et al.
Published: (2023-12-01)

Gut Microbiota Changes and Its Potential Relations with Thyroid Disorders: From Composition to Therapeutic Targets
by: Yang C, et al.
Published: (2024-08-01)

Orbital lymphocyte populations in three states of thyroid eye disease
by: Shane M. Griffin, et al.
Published: (2023-09-01)

Thyroid Receptor Antibody and the Development of Graves’ Orbitopathy: Clinical Experience of using Radioiodine Ablation in the Management of Graves’ Orbitopathy in post-iodine ablation hypothyroid patient
by: Edelyn Christina, et al.
Published: (2023-06-01)

Characterization of orbital tumors and simulating lesions diagnosed in a referral hospital in Colombia during 2010–2020: 84 cases
by: Luis Alberto Ruiz Robles, et al.
Published: (2023-01-01)

Clinical outcomes of radiotherapy as initial local therapy for Graves’ ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery
by: Prabhu Roshan S, et al.
Published: (2012-06-01)

A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease
by: Myra B. Safo, et al.
Published: (2021-06-01)

How patients experience thyroid eye disease
by: Terry J. Smith, et al.
Published: (2023-11-01)

Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: a systematic review and meta-analysis
by: Nicole Tsz Yan Wong, et al.
Published: (2023-08-01)

Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves’ orbitopathy
by: Yeonjung Yoon, et al.
Published: (2024-09-01)

Rituximab in the treatment of Graves’ orbitopathy: latest updates and perspectives
by: Jakub Supronik, et al.
Published: (2022-11-01)

Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients
by: Danilo Villagelin, et al.
Published: (2019-04-01)